Functionally distinct T-cell epitopes within the hepatitis C virus non- structural 3 protein

Human Immunology

Volumn 60, Issue 2, 1999, Pages 105-115

  Tabatabai, Niloofar M ^a   Bian, Tong Hua ^a   Rice, Charles M ^b   Yoshizawa, Kaname ^c   Gill, Joan ^a   Eckels, David D ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Epitopes; HCV; T cells; Viral immunology

Indexed keywords

EPITOPE; HEPATITIS C ANTIGEN;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; T LYMPHOCYTE ACTIVATION;

CELL DIVISION; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; PEPTIDES; RECOMBINANT PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0032911169     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00102-5     Document Type: Article

References (41)

1. Eckels D.D., Flomenberg P., Gill J.C. Hepatitis C virus models of immunopathogenesis and prophylaxis . Transfusion. 36:(9):1996;836-844.
2. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
3. Chaudhary R.K., MacLean C. Evaluation of first- and second-generation RIBA kits for detection of antibody to Hepatitis C Virus. J Clin Microbiol. 29:(10):1991;2329-2330.
4. Mita E., Hayashi N., Ueda K., Kasahara A., Fusamoto H., Takamizawa A., Matsubara K., Okayama H., Kamada T. Expression of MBP-HCV NS1/E2 fusion protein in E coli and detection of anti-NS1/E2 antibody in type C chronic liver disease . Biochemical and Biophysical Research Communications. 183:(3):1992;925-930.
5. Sallberg M., Ruden U., Wahren B., Magnius L.O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol. 30:1992;1989-1994.
6. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 67:1993;3923-3930.
7. Simmonds P., Rose K.A., Graham S., Han S.W., McOmish F., Dow B.C., Follet E.A.C., Yap P.L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV) use of type-specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3 . J Clin Microbiol. 31:1993;1493-1503.
8. Neville J.A., Prescott L.E., Bhattacherjee V., Adams N., Pike I., Rodgers B., El-Zayadi A., Hamid S., Dusheiko G.M., Saeed A.A., Haydon G.H., Simmonds P. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol. 35:(12):1997;3062-3070.
9. Romagnani S. Lymphokine production by human T cells in disease states. Annual Rev Immunol. 12:1994;227-257.
10. Fishman M.A., Perelson A.S. Th1/Th2 cross regulation. Journal of Theor Biol. 170:1994;25-56.
11. Gooding L.R. Virus proteins that counteract host immune defenses. Cell. 71:1992;5-7.
12. Clerici M., Shearer G.M. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today. 14:(3):1993;107-111.
13. Sieling P.A., Abrams J.S., Yamamura M., Salgame P., Bloom B.R., Rea T.H., Modlin R.L. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. Journal of Immunology. 150:(12):1993;5501-5510.
14. Panuska J.R., Merolla R., Rebert N.A., Hoffmann S.P., Tsivitse P., Cirino N.M., Silverman R.H., Rankin J.A. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages Suppression of early cytokine production and implications for incomplete immunity . J Clin Invest. 96:1995;2445-2453.
15. Cacciarelli T.V., Martinez O.M., Gish R.G., Villanueva J.C., Krams S.M. Immunoregulatory cytokines in chronic Hepatitis C Virus infection pre- and posttreatment with interferon alpha . Hepatology. 24:1996;6-9.
16. Reiser M., Marousis C.G., Nelson D.R., Lauer G., González-Peralta R.P., Davis G.L., Lau J.Y. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. Journal of Hepatology. 26:(3):1997;471-478.
17. Tsai S.L., Liaw Y.F., Chen M.H., Huang C.Y., Kuo G.C. Detection of type 2-like T-helper cells in hepatitis C virus infection implications for hepatitis C virus chronicity . Hepatology. 25:(2):1997;449-458.
18. Woitas R.P., Lechmann M., Jung G., Kaiser R., Sauerbruch T., Spengler U. CD30 induction and cytokine profiles in Hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol. 159:1997;1012-1018.
19. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga E.A., Santantonio T., Jung M.C., Eichenlaub D., Pape G.R. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:(8981):10-14-1995;1006-1007.
20. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1995;John Wiley & Sons, Inc, New York.
21. Gillis S., Smith K.A. Long term culture of tumour-specific cytotoxic T cells. Nature. 268:1977;154-156.
22. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Ann Rev Immunol. 11:1993;165-190.
23. Koziel M.J. Immunology of viral hepatitis. Am J Med. 100:(1):1996;98-109.
24. Koziel M.J., Dudley D., Wong J.T., Dienstag J., Houghton M., Ralston R., Walker B.D. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1992;3339-3344.
25. Koziel M.J., Wong D.K., Dudley D., Houghton M., Walker B.D. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis. 176:(4):1997;859-866.
26. Rice C.M., Walker C.M. Hepatitis C virus-specific T lymphocyte responses. Current Opinion in Immunology. 7:(4):1995;532-538.
27. Missale G., Bertoni R., Lamonaca V., Valli A., Massari M., Mori C., Rumi M.G., Houghton M., Fiaccadori F., Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 98:(3):8-1-1996;706-714.
28. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol. 71:(8):1997;6011-6019.
29. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., Lau J.Y. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol. 158:(3):2-1-1997;1473-1481.
30. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-γ and its receptor. Ann Rev Immunol. 11:1993;571-611.
31. Vieira P., De Waal-Malefyt R., Dang M.-N., Johnson K.E., Kastelein R., Fiorentino D.F., de Vries J.E., Roncarolo M.-G., Mosmann T.R., Moore K.W. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones homology to Epstein-Barr virus open reading frame BCRFI . Proc Natl Acad Sci USA. 88:1991;1172-1176.
32. Taga K., Mostowski H., Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood. 81:(11):1993;2964-2971.
33. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
34. Jin L., Peterson D.L. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys. 323:(1):10-20-1995;47-53.
35. Yao N.H., Hesson T., Cable M., Hong Z., Kwong A.D., Le H.V., Weber P.C. Structure of the hepatitis C virus RNA helicase domain. Nature Structural Biol. 4:(6):1997;463-467.
36. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., Rice C.M. Characterization of the hepatitis C virus-encoded serine proteinase determination of proteinase-dependent polyprotein cleavage sites . J Virol. 67:(5):1993;2832-2843.
37. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O'Malley E.T., Harbeson S.L., Rice C.M., Murcko M.A., Caron P.R., Thomson J.A. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 87:(2):1996;343-355.
38. Napoli J., Bishop G.A., McGuinness P.H., Painter D.M., McCaughan G.W. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:1996;759-765.
39. Gerosa F., Paganin C., Peritt D., Paiola F., Scupoli M.T., Aste-Amezaga M., Frank I., Trinchieri G. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both Interferon-gamma and interleukin-10. J Exp Med. 183:1996;2559-2569.
40. Windhagen A., Anderson D.E., Carrizosa A., Williams R.E., Hafler D.A. IL-12 induces human T cells secreting IL-10 with IFN-gamma. J Immunol. 157:(3):8-1-1996;1127-1131.
41. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:(6652):10-16-1997;737-742.